BioDuro is a U.S-owned global Contract Research, Development, and Manufacturing Organization (CRDMO) that partners with biotech and pharmaceutical companies to accelerate drug development from discovery through commercialization. Our fully integrated services span discovery chemistry, biology, DMPK, drug substance, and drug product development across broad molecular modalities including small molecules, PROTACs, peptides, oligonucleotides, and antibody-drug conjugates. 

Founded in 1996, BioDuro has over 2,000 scientists, 1,500+ active customers from small biotech to global top pharma, and operates across 7 global sites, serving clients in 30+ countries. We have supported 500+ INDs (FDA/NMPA) and manufactured 20+ commercial drug products to date. 

We leverage our broad capabilities and specialized technology platforms to empower partners worldwide. Our integrated approach helps de-risk programs, accelerate timelines, and deliver higher-value outcomes.